Primarily evaluation of the efficacy of fortec in the treatment of the hepatitis B
- Author:
Chuong Xuan Tran
- Publication Type:Journal Article
- Keywords:
Hepatitis B
- MeSH:
Hepatitis B;
Medicine, Traditional
- From:Journal of Practical Medicine
2000;383(6):41-43
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Fortec (Biphenyl Dimethyl Dicarboxylate) was synthesized from Fructus Schisandrae, one traditional medicine of China. A randomized, compared trial was carried out at Department of Infectious Disease, Hue Central Hospital from 06.1997 to 12.1999, by using Fortec in treatment of viral hepatitis B. 108 patients with acute and chronic hepatitis B were divided into 2 groups. One group took Fortec and the other did not. The patients with acute hepatitis B had not any difference in two groups except the clinical symptoms such as fatigue and anorexia were faster improved in the group taking Fortec also showed to be improved after 3 weeks of treatment. After 6 weeks SGPT was normalized in 82,4% patients from the Fortec group in comparison with 64% in non Fortec group with p<0,01, Prothrombin time was normalized in 76,4% patients in the first group compared with 60% in second group. No side effect was recognized. Fortec is effective in treatment of viral hepatitis B, especially chronic hepatitis.
